18
https://pubmed.ncbi.nlm.nih.gov/38112227
Serum miR-105-3p level is a potential prognostic biomarker for thyroid cancer patients after surgery, with its expression correlating with degree of differentiation, lymph node metastasis, and changing dynamically over time post-surgery.
